Discover the power of real-time signals plus AI
Every funding round, exec hire, M&A move, contract, and sentiment shift on BranchLab — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
Branch Lab Raises $26 M Series A Led By Mc Kesson Ventures To Enhance Pharma Commercialization With Ai Technology. announced it raised $28.8 Million in an initial filing from an offering of $28.8 Million
Amount Raised
$28.8 Million
Round Type
series a
Investors
Description
BranchLab, an AI platform transforming how pharmaceutical companies commercialize therapies, has announced a $26 million Series A financing led by McKesson Ventures. This funding will support BranchLab’s efforts in delivering a unified, privacy-first AI platform that increases commercialization efficacy. The round brings total funding to $35 million, with participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures. The platform promises to provide real-time insights for pharma teams, enhancing their operational capabilities significantly.
Related People
Sign in to view contact details
Funding Insights
Based on industry dataWatching BranchLab? See every signal — funding, hires, M&A, contracts, sentiment.
See plans